54 Biggest Movers From Friday

Gainers

• Biomerica, Inc. (NASDAQ:BMRA) shares surged 38% to close at $6.21 on Friday. Biomerica entered into a Supplier Agreement with Walmart to sell its EZ Detect colorectal disease screening test within the Walmart retail system.
• Exscientia Limited (NASDAQ:EXAI) rose 23.2% to settle at $27.10 after the company priced its IPO at $22 per ADS.
• First Watch Restaurant Group, Inc. (NASDAQ:FWRG) gained 22.9% to close at $22.13 after pricing its IPO at $18 a share.
• Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) rose 19.8% to close at $42.01 following data from Merck & Co's investigational oral antiviral molnupiravir, which boosted sentiment for Atea Pharmaceutical's AT-527, an oral antiviral drug candidate.
• ENGlobal Corporation (NASDAQ:ENG) surged 19.1% to settle at $3.18.
• Vicinity Motor Corp.(NASDAQ:VEV) gained     18.7% to settle at $5.90. Vicinity Motor partnered with Aereus Technologies to offer its CuVerro Shield technology, an antimicrobial treatment option for high-touch areas of Vicinity vehicles.
• Bitfarms Ltd (NASDAQ:BITF) climbed 18.4% to close at $5.03 amid an increase in the price of Bitcoin and Ethereum.
• Progenity, Inc. (NASDAQ:PROG) rose 17.8% to settle at $1.79 on Friday after jumping over 40% on Thursday.
• Silverback Therapeutics, Inc. (NASDAQ:SBTX) jumped 16.9% to close at $11.67.
• Quotient Limited (NASDAQ:QTNT) surged 16.2% to settle at $2.72. Quotient reported commencement of review process of expanded immunohematology technical file dossier by European Notified Body.
• Global Blue Group Holding AG (NYSE:GB) gained 16.1% to close at $7.50.
• Liberty TripAdvisor Holdings, Inc. (NASDAQ:LTRPA) surged 15.8% to close at $3.58.
• LSB Industries, Inc. (NYSE:LXU) gained 14.9% to close at $11.73.
• Broadwind, Inc. (NASDAQ:BWEN) jumped 14.7% to settle at $2.97.
• Ramaco Resources, Inc. (NASDAQ:METC) rose 14.1% to close at $14.04.
• Wheels Up Experience Inc. (NYSE:UP) gained 14% to settle at $7.51. Credit Suisse analyst Stephen Ju initiated Wheels Up Experience with an Outperform rating and a price target of $14.
• StarTek, Inc. (NYSE:SRT) surged 13.4% to close at $6.25.
• Navios Maritime Holdings Inc. (NYSE:NM) gained 13% to settle at $5.39.
• Triumph Group, Inc. (NYSE:TGI) surged 12.5% to close at $20.95. Triumph Group’s Triumph Product Support site in Grand Prairie, Texas, recently extended a repair management agreement with MTU Maintenance as a repair services supplier for engine accessories and line replacement units (LRUs) applicable to the V2500, CFM56, CF6, and CF34 engine platforms.
• Sono-Tek Corporation (NASDAQ:SOTK) gained 12.1% to close at $4.5950.
• Luby's, Inc. (NYSE:LUB) climbed 11.2% to close at $4.65.
• SunPower Corporation (NASDAQ:SPWR) gained 9.7% to close at $24.87. SunPower will replace Cimarex Energy in the S&P MidCap 400 effective on Tuesday, October 5.
• Salem Media Group, Inc. (NASDAQ:SALM) gained 9.2% to close at $4.05.
• Merck & Co., Inc. (NYSE:MRK) gained 8.4% to settle at $81.40 after the company and Ridgeback announced investigational oral antiviral molnupiravir reduced risk of hospitalization or death by about 50% versus the placebo for patients with mild to moderate COVID-19 in Phase 3 interim analysis.
• QuickLogic Corporation (NASDAQ:QUIK) gained 8.2% to settle at $5.80. QuickLogic reported a strategic investment by current shareholders. The company said it expects Q3 revenue of $3.8 million to $3.9 million.
• Iterum Therapeutics plc (NASDAQ:ITRM) rose 7.7% to close at $0.6011 after dropping over 8% on Thursday.

Check out these big penny stock gainers and losers

Losers

• Spire Global, Inc.. (NYSE:SPIR) shares fell 43.3% to close at $7.10 on Friday. Spire Global, Inc. recently appointed Dr. Kevin Petty as Vice President of Weather.
• Omeros Corporation (NASDAQ:OMER) shares dipped 38.1% to close at $8.54 on Friday after the company announced the FDA notified it that they identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time.
• Adagio Therapeutics, Inc. (NASDAQ:ADGI) dropped 33.8% to close at $27.98. Adagio Therapeutics recently announced new data from its COVID-19 antibody program.
• NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) fell 32.8% to close at $2.50 after the company announced a 4.3 million share offering at $3.25 per share.
• Farmmi, Inc. (NASDAQ:FAMI) fell 23.6% to close at $0.3536. Farmmi recently agreed to acquire all the shares of Jiangxi Xiangbo Agriculture and Forestry Development Co., Ltd (Xiangbo) for about RMB70 million.
• Vir Biotechnology, Inc. (NASDAQ:VIR) dropped 21.1% to close at $34.35 in reaction to promising data from competitor Merck's COVID-19 antiviral candidate.
• Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) dropped 19.3% to settle at $4.30. Clarus Therapeutics filed for offer and sale of up to 19.82 million shares of common stock by selling stockholders.
• Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 18.3% to close at $3.27.
• Lordstown Motors Corp. (NASDAQ:RIDE) shares fell 18.2% to close at $6.53. Lordstown Motors issued production and financial update. Foxconn will purchase $50 million of Lordstown common stock at price of $6.8983 per share.
• IronNet, Inc.. (NASDAQ:IRNT) shares fell 17.4% to settle at $14.08 after dropping 15% on Thursday.
• Immunome, Inc. (NASDAQ:IMNM) fell 17.2% to settle at $20.16. Immunome will present preclinical data on anti IL-38 antibody program at The American Association for Cancer Research NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
• IRSA Propiedades Comerciales S.A. (NASDAQ:IRCP) dropped 15.3% to close at $2.50.
• Benson Hill Inc. (NASDAQ:BHIL) fell 15.2% to close at $6.05.
• Camber Energy, Inc. (NYSE:CEI) shares declined 14.9% to settle at $3.25 after gaining over 11% on Thursday.
• CureVac N.V. (NASDAQ:CVAC) fell 14.7% to close at $46.57 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.
• Guardant Health, Inc. (NASDAQ:GH) dropped 14% to settle at $107.51 following a Bloomberg report suggesting the company is exploring an acquisition of NeoGenomics.
• Superior Drilling Products, Inc. (NYSE:SDPI) shares declined 13.1% to close at $1.52 after jumping 60% on Thursday.
• DatChat, Inc. (NASDAQ:DATS) dropped 12.6% to close at $11.93.
• Novavax, Inc. (NASDAQ:NVAX) fell 12.4% to close at $181.60 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%.
• Dynavax Technologies Corporation (NASDAQ:DVAX) declined 12.3% to close at $16.84 on Friday.
• Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) fell 11.8% to settle at $43.27.
• IonQ, Inc. (NYSE:IONQ) dipped 11.5% to close at $9.20.
• Moderna, Inc. (NASDAQ:MRNA) dropped 11.4% to close at $341.09 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. Stephane Bancel, Chief Executive Officer at Moderna, made a large insider sell on September 30, according to a new SEC filing.
• Valens Semiconductor Ltd. (NYSE:VLN) fell 11% to settle at $6.59.
• Lyell Immunopharma, Inc. (NASDAQ:LYEL) dipped 10.2% to close at $13.29.
• Lucira Health, Inc. (NASDAQ:LHDX) dropped 9.3% to close at $6.89. Lucira Health recently appointed Tony Allen as COO.
• BioNTech SE (NASDAQ:BNTX) fell 6.7% to close at $254.79 in reaction to positive data from Merck's oral antiviral molnupiravir, which reduced risk of hospitalization or death by roughly 50%. BioNTech dosed the first patient with its individualized mRNA cancer vaccine BNT122 (autogene cevumeran, RO7198457) in Phase 2 clinical trial.
• Alzamend Neuro, Inc. (NASDAQ:ALZN) fell 6.5% to close at $2.88. Ascendiant Capital analyst Edward Woo initiated coverage on Alzamend Neuro with a Buy rating and announced price target of $8.